Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IN8BIO, INC. Director's Dealing 2022

Aug 18, 2022

35200_dirs_2022-08-18_f9d3535d-db1a-49cf-b1c2-184e03d72cf1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2022-08-16

Reporting Person: Roemer Alan S. (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-08-16 Common Stock P 26315 $1.90 Acquired 55989 Direct